KELLY FERRARA: Open Payments
NPI 1598326571 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 106 payments from 27 companies in 2025. Trend: 2023 $1,516 · 2024 $1,930 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $204 |
| Radius Health, Inc. | 8 | $199 |
| Amgen Inc. | 12 | $181 |
| Abbott Laboratories | 7 | $151 |
| IBSA Pharma Inc. | 8 | $151 |
| Xeris Pharmaceuticals, Inc. | 11 | $144 |
| Tandem Diabetes Care, Inc. | 5 | $138 |
| Medtronic, Inc. | 5 | $110 |
| Corcept Therapeutics | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $81 |
Products named: FREESTYLE LIBRE 3, Tirosint, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, MINIMED 780G, Korlym, Kerendia.
Industry payments across FL — which companies pay providers there.
